Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-003 · Eligibility
DQ-001: Adult-only validated pathway
Adult-only validated pathway. Evaluates age years below 18.
Condition
- Any of:
- age years < 18
- age years missing
What it reports
- Analysis status: excluded or data insufficient
- Message: CPE-003 v1.1 is validated for adults only; route to pediatric kidney pathway or request age.
Evidence
- R1KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Disease: Improving Global Outcomes (KDIGO), 2024.Supports: CKD definition and chronicity CGA classification albuminuria confirmation risk prediction referral medication stewardship progression monitoring
- R3eGFR Equations for Adults: 2021 CKD-EPI creatinine and creatinine-cystatin C race-free equations. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / NIH, 2026.Supports: eGFRcr computation eGFRcr-cys computation assay standardization adult eligibility
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
CKD-FX-015
ACE inhibitor monitoring rather than automatic cessation
ACE inhibitor monitoring rather than automatic cessation
CKD-FX-016
ACE inhibitor creatinine rise requiring evaluation
ACE inhibitor creatinine rise requiring evaluation
CKD-FX-020
SGLT2i early eGFR dip
SGLT2i early eGFR dip
CKD-EX-01
A 12-year-old is outside the adult pathway
Pediatric patients are routed out; no classification is produced.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.